Based in Los Angeles, the company was valued at roughly $550 million as of February 2022, and currently (as of May 2026) has a valuation of around $380 million
Whether youre navigating chronic fatigue, inflammation, gut dysfunction, or hormonal shifts, our team blends advanced testing , personalized supplementation , lifestyle changes, and medication when needed to create a plan that actually works for you
National consensus is that there are in severely deficient patients and those with malabsorption
A robust immune system supports your overall health and helps you stay well
Medicare Part B and some Part D plans may cover Nucala, but the patient may still be responsible for copays and coinsurance
Kept most of my strength in the gym which shocked me